Heparin--a key drug in the treatment of the circulatory degenerative diseases: controlling its action with polymers

Curr Pharm Des. 2012;18(18):2591-606. doi: 10.2174/138161212800492840.

Abstract

The properties of heparin, a key anticoagulant, are reviewed. The important issues in heparinotherapy, i.e., reaching quick anticoagulant effect, maintaining therapeutic level of anticoagulation, heparin inhibition and non-invasive heparin formulations have been reviewed and discussed, with the focus on the role of polymeric substances in the proposed solutions.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Anticoagulants / administration & dosage
  • Anticoagulants / adverse effects
  • Anticoagulants / chemistry
  • Anticoagulants / therapeutic use*
  • Delayed-Action Preparations
  • Drug Carriers / chemistry*
  • Hemorrhage / prevention & control
  • Heparin / administration & dosage
  • Heparin / adverse effects
  • Heparin / chemistry
  • Heparin / therapeutic use*
  • Heparin Antagonists / therapeutic use
  • Humans
  • Molecular Structure
  • Neurodegenerative Diseases / blood
  • Neurodegenerative Diseases / drug therapy*
  • Polymers / chemistry*

Substances

  • Anticoagulants
  • Delayed-Action Preparations
  • Drug Carriers
  • Heparin Antagonists
  • Polymers
  • Heparin